BENODEX 0.5mg Caplet

Dexamethasone 0.5 mg

COMPOSITIONS :

Benodex® Caplet 0.5 mg, each caplet contains : Dexamethasone 0.5 mg.

 

DESCRIPTIONS :

Benodex® with active ingredient Dexamethasone is available as caplet 0.5 mg and 0.75 mg.

 

INDICATIONS :

  • Primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, hypercalcemia caused by
  • Perennial rhinitis allergic, bronchial asthma, contact dermatitis, atopic dermatitis, serum sickness, drug hypersensitivity reactions.
  • Eye diseases due to inflammation or allergies, and not caused by a virus.
  • As adjunctive therapy for short-term administration as in : Psoriatic arthritis, rheumatoid arthritis, rheumatoid arthritis “Juvenile”.
  • Systemic Lupus Erythematosus (SLE), acute rheumatic carditis.
  • Pemphigus, bullous dermatitis herpetiformis, severe erythema multiforme (“Steven’s-Johnson syndrome”).
  • Sarcoidosis
  • Cerebral edema.
  • The effect for the type of vasogenic edema as a result of brain tumors, particularly metastases and glioblastoma.
  • It may be helpful to : Idiopathic hemolytic anemia and autoimmune.
  • Subacute hepatic necrosis, autoimmune chronic active hepatitis.

 

DOSAGE AND ADMINISTRATIONS :

Adult :

Initial dose variable       : 0.75 – 9 mg/day, 2 – 4 times daily or depending on the severity of the disease.

Mild disease                 : < 0.75 mg.

Severe disease              : > 9 mg.

 

CONTRAINDICATIONS :  

  • Systemic fungal infections.
  • Ocular herpes simplex.
  • Patients who are sensitive to the drug and its components.

 

WARNINGS AND PRECAUTIONS :

  • Sensitivity with infection in patients who received corticosteroids is not specific to a particular bacterial or fungal pathogens. When an infection occur the dose is maintained or increased and best treatment should be done against the infection.
  • Long-term use of corticosteroids may result in subcapsular cataract pasterior, glaucoma with possible damage of the optic nerves and may enhance the secondary ocular infections due to fungi and viruses.
  • Corticosteroids is not recommended for the first trimester pregnant women because the possibility of newborn babies suffering from symptoms of hypoadrenalism.
  • Not recommended use in lactating women because the possibility of corticosteroids are secreted into breast milk.
  • Secondary adrenocortical insufficiency due to the use of these drugs may be reduced by lowering the dose gradually.
  • Coadministration Acetosal with corticosteroids is not recommended in patients with hypoprothrombinemia.
  • Administration of these drugs can suppress the clinical symptoms of an infectious disease.
  • Long-term use can lower the body’s immunity to infectious diseases.
  • Corticosteroids is not recommended in patients with nonspecific ulcerative colitis, if there is a tendency perforation, abscess and other pyogenic infection, diverticulitis, fresh intestinal anastomoses, peptic ulcer, renal insufficiency, hypertension, osteoporosis, myasthenia gravis.
  • Not recommended for children under 6 years old, carefully observe the children and babies who use corticosteroids in the long term to the growth and development of children.
  • Administration of corticosteroids in patients with hypothyroid and cirrhosis may increase corticosteroids effects.
  • Use with caution of these corticosteroids in patients with diabetes, because it can increase gluconeogenesis and reduced insulin sensitivity.

 

PRESENTATIONS :

Benodex® Caplet 0.5 mg                      Box, 10 blisters @ 10 caplets                                                          Reg. No. DKL1502350804A1

 

STORAGE :

STORE BELOW 30°C, PROTECT FROM LIGHT

 

ON MEDICAL PRESCRIPTION ONLY

 

Manufactured by :

PT. BERNOFARM

Sidoarjo – Indonesia